Topical formulations for use in the treatment or prevention of skin cancers
GB0425633D0
Topical formulations for use in the treatment or prevention of dermatological conditions
GB0415830D0
Chromatographic separation of trilostane mixture
GB0411464D0
Method for the preparation of trilostane
EP1385527A1
Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
EP1255553A2
Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
